» Articles » PMID: 31063125

Molecular Epidemiology of Otomycosis in Isfahan Revealed a Large Diversity in Causative Agents

Overview
Journal J Med Microbiol
Specialty Microbiology
Date 2019 May 8
PMID 31063125
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To elucidate the clinical and microbial epidemiology of otomycosis in Isfahan, Iran.

Methodology: From January 2016 to January 2017 all patients clinically suspected of otomycosis at Al-Zahra Hospital, Isfahan, Iran were recruited. Specimens were taken using sterile swabs by an otorhinolaryngologist and subjected to culture and microscopy using potassium hydroxide and Giemsa stain. Isolated fungi were identified based on morphological and molecular characteristics.

Results: Otomycosis was confirmed in 97/120 patients (80.8 %). Females (72.2 %) and patients aged 30-39 years (33 %) were more commonly affected than others. Manipulation of ear canal (62.9 %) was the most common predisposing factor. Pruritus was observed in 84.54  % of the patients followed by hearing impairment (81.4 %), and most episodes were detected over the summer (50.5 %). Culture was positive for 81 (83.5  %) of confirmed cases and molds were the most prevalent causative agents (n=51, 63 %) followed by yeasts (n=19, 23.4 %) and yeast/mold mixes (n=11, 13.6 %). For the 16 remaining patients, no growth was seen in culture despite a positive result on direct examination. In total, 92 isolates (63 molds and 29 yeasts) were recovered in culture. Application of molecular methods showed 18 fungal species and the vast majority of them belonged to Aspergillus (n=53, 57.6 %) and Candida genus. Among the species involved, Candida parapsilosis (n=22, 22.7 %) and Aspergillus tubingensis (n=15, 15.5 %) were the most encountered species.

Conclusion: Outcomes from this study showed a different picture of prevalence, where C. parapsilosis and A. tubingensis but not Aspergillus niger were the most species encountered from patients suffering from otomycosis.

Citing Articles

Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list.

Asogan M, Kim H, Kidd S, Alastruey-Izquierdo A, Govender N, Dao A Med Mycol. 2024; 62(6).

PMID: 38935912 PMC: 11210616. DOI: 10.1093/mmy/myad131.


An Autochthonous Susceptible Clade I Otomycosis Case in Iran.

Ahmadi B, Naeimi B, Ahmadipour M, Morovati H, de Groot T, Spruijtenburg B J Fungi (Basel). 2023; 9(11).

PMID: 37998906 PMC: 10671974. DOI: 10.3390/jof9111101.


Identification of Microbial Community in Otomycosis by Metagenomic Next Generation Sequencing (mNGS): Potential Implication of Treatment with Terbinafine.

Xu S, Zhang X, Yang Q, Li J, Yu Z Mycopathologia. 2023; 188(6):995-1005.

PMID: 37723360 DOI: 10.1007/s11046-023-00791-5.


Candida parapsilosis complex in the clinical setting.

Govrins M, Lass-Florl C Nat Rev Microbiol. 2023; 22(1):46-59.

PMID: 37674021 DOI: 10.1038/s41579-023-00961-8.


Molecular and microscopy detection of in hospitalized patients during the COVID-19 pandemic.

Matouri R, Aboutalebian S, Nasri E, Sadeghi S, Rostami S, Fakhim H Front Med (Lausanne). 2023; 10:1148320.

PMID: 37089605 PMC: 10117983. DOI: 10.3389/fmed.2023.1148320.